April 24, 2018 11:39 AM ET


Company Overview of NeuroTherapeutics Pharma, Inc.

Company Overview

NeuroTherapeutics Pharma, Inc. develops and markets therapeutics for patients suffering from central nervous system (CNC) disorders. The company focuses on developing a pipeline of compounds and medicines for the treatment of neuropathic pain, inflammatory pain, acute pain, epilepsy, anxiety, autism, migraine, schizophrenia, and bipolar. Its lead product NTP-2014 is a molecule compound that has applications in various diseases, including epilepsy, pain, and other CNS indications. The company was incorporated in 2006 and is based in Chicago, Illinois.

8750 West Bryn Mawr Avenue

Suite 440

Chicago, IL 60631

United States

Founded in 2006





Key Executives for NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NeuroTherapeutics Pharma, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.